Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.

Biederman J, Spencer T, Wilens T.

Int J Neuropsychopharmacol. 2004 Mar;7(1):77-97. Epub 2004 Jan 21. Review.

PMID:
14733627
[PubMed - indexed for MEDLINE]
2.

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.

Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S.

J Am Acad Child Adolesc Psychiatry. 1996 Apr;35(4):409-32. Review.

PMID:
8919704
[PubMed - indexed for MEDLINE]
3.

Pharmacological management of attention-deficit hyperactivity disorder.

Reeves G, Schweitzer J.

Expert Opin Pharmacother. 2004 Jun;5(6):1313-20. Review.

PMID:
15163276
[PubMed - indexed for MEDLINE]
4.

Mechanism of action of agents used in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychiatry. 2006;67 Suppl 8:32-8. Review.

PMID:
16961428
[PubMed - indexed for MEDLINE]
5.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
[PubMed - indexed for MEDLINE]
6.

Pharmacological treatment of attention-deficit/hyperactivity disorder in adults.

Slatkoff J, Greenfield B.

Expert Opin Investig Drugs. 2006 Jun;15(6):649-67. Review.

PMID:
16732717
[PubMed - indexed for MEDLINE]
7.

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.

Peterson K, McDonagh MS, Fu R.

Psychopharmacology (Berl). 2008 Mar;197(1):1-11. Epub 2007 Nov 17. Review.

PMID:
18026719
[PubMed - indexed for MEDLINE]
8.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
[PubMed - indexed for MEDLINE]
9.

The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.

Himpel S, Banaschewski T, Heise CA, Rothenberger A.

Expert Opin Drug Saf. 2005 Mar;4(2):311-21. Review.

PMID:
15794722
[PubMed - indexed for MEDLINE]
10.

Non-stimulant treatment of attention-deficit/hyperactivity disorder.

Pliszka SR.

CNS Spectr. 2003 Apr;8(4):253-8. Review.

PMID:
12679740
[PubMed - indexed for MEDLINE]
11.

Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.

Huang YS, Tsai MH.

CNS Drugs. 2011 Jul;25(7):539-54. doi: 10.2165/11589380-000000000-00000. Review. Erratum in: CNS Drugs. 2011 Nov 1;25(11):932. Dosage error in article text.

PMID:
21699268
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
[PubMed - indexed for MEDLINE]
13.

Pharmacologic treatment of attention-deficit hyperactivity disorder.

Greydanus DE.

Indian J Pediatr. 2005 Nov;72(11):953-60. Review.

PMID:
16391451
[PubMed - indexed for MEDLINE]
14.

Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder.

Kaplan G, Newcorn JH.

Pediatr Clin North Am. 2011 Feb;58(1):99-120, xi. doi: 10.1016/j.pcl.2010.10.009. Review.

PMID:
21281851
[PubMed - indexed for MEDLINE]
15.

Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.

Waxmonsky JG.

Essent Psychopharmacol. 2005;6(5):262-76. Review.

PMID:
16222911
[PubMed - indexed for MEDLINE]
16.

New drugs for the treatment of attention-deficit/hyperactivity disorder.

Pataki CS, Feinberg DT, McGough JJ.

Expert Opin Emerg Drugs. 2004 Nov;9(2):293-302. Review.

PMID:
15571486
[PubMed - indexed for MEDLINE]
17.

Psychopharmacology of ADHD in adolescents.

Greydanus DE, Sloane MA, Rappley MD.

Adolesc Med. 2002 Oct;13(3):599-624. Review.

PMID:
12270803
[PubMed - indexed for MEDLINE]
18.

Novel treatments for attention-deficit/hyperactivity disorder in children.

Spencer TJ, Biederman J, Wilens TE, Faraone SV.

J Clin Psychiatry. 2002;63 Suppl 12:16-22. Review.

PMID:
12562057
[PubMed - indexed for MEDLINE]
19.

The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.

Sallee FR.

Postgrad Med. 2010 Sep;122(5):78-87. doi: 10.3810/pgm.2010.09.2204. Review.

PMID:
20861591
[PubMed - indexed for MEDLINE]
20.

Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.

Santosh PJ, Sattar S, Canagaratnam M.

CNS Drugs. 2011 Sep 1;25(9):737-63. doi: 10.2165/11593070-000000000-00000. Review.

PMID:
21870887
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk